Uncover effective strategies for thyroid health with a functional medicine approach that promotes natural healing.

Educational Abstract: Rethinking Thyroid Health Through Integrative, Evidence-Based Care

As a clinician and educator, I am often asked whether lifelong thyroid medication is the only solution for persistent symptoms like fatigue, weight gain, cold intolerance, brain fog, and mood changes. In this educational post, I present a clear, first-person walkthrough of how I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, evaluate and support patients with thyroid-related complaints through a multidisciplinary, research-informed approach.

I discuss the physiology of thyroid hormone production and conversion, why so many patients remain symptomatic despite T4 therapy, and how systemic inflammation, hepatic steatosis, gastrointestinal dysbiosis, and HPA-axis stress responses can disrupt T4-to-T3 conversion. I explore the roles of deiodinases D1, D2, and D3; the enterohepatic circulation of thyroid hormones; bile dynamics; and leptin-insulin signaling in hepatic T4-to-T3 conversion. I share a patient journey involving severe symptoms while on levothyroxine and how we identified root-cause disruptors without relying solely on additional prescriptions.

This post also explains how our clinic integrates chiropractic care, functional medicine, medical oversight, rehabilitation, and injury care to support whole-person health. Our team operates in El Paso, Texas, at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic), where I work closely with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. With over 40 years of internal medicine experience, Dr. Cardenas provides medical direction and oversight as we incorporate evidence-based diagnostics and therapies, including integrative chiropractic strategies, rehabilitative exercise, metabolic and nutrition support, stress resilience training, and patient education.

In the sections that follow, I provide:

• A first-person narrative of thyroid physiology and pathophysiology
• An integrative case exploration illustrating non-pharmacologic mechanisms that can drive symptoms
• Evidence-based protocols for improving peripheral conversion and reducing reverse T3, grounded in physiology
• An explanation of how integrative chiropractic care supports neuro-immune-metabolic regulation and mechanical factors influencing hepatic and gastrointestinal function
• Practical clinical workflows, lab strategies, and rehabilitation techniques we use in real-world settings, under medical supervision
• Key checkpoints to avoid common pitfalls like aggressive calorie restriction during metabolic recovery, unrecognized inflammatory drivers, and dysbiosis-related hormone clearance issues

By the end, you will have an accessible but thoroughly detailed understanding of how integrative, medically supervised care can address thyroid-related dysfunction in the context of whole-person health. This post reflects the latest findings from leading researchers. It uses modern, evidence-based methods to illuminate why patients may struggle on T4 therapy alone—and how a multidisciplinary clinic can tailor care to restore function, safely and effectively.

Keywords emphasized throughout include: thyroid hormone, T4-to-T3 conversion, deiodinases (D1, D2, D3), reverse T3, systemic inflammation, dysbiosis, bile physiology, enterohepatic circulation, HPA axis, leptin, insulin, hepatic glycogen, integrative chiropractic care, functional medicine, rehabilitation, and medical oversight.

Integrative Thyroid Care: A First-Person Journey into Physiology, Patient Stories, and Whole-Person Solutions

Introduction: Why So Many Patients Still Feel Unwell on T4

I have spent decades at the intersection of spine health, functional medicine, and integrated clinical practice. In that time, I have seen countless individuals—many of them women in their 30s to 50s—who were placed on levothyroxine or other T4-based medications yet remained cold, exhausted, depressed, and overwhelmed by weight gain and brain fog.

I remember one patient’s story vividly. She was 41 and had been prescribed both Synthroid and levothyroxine by various providers. Despite adherence, she felt progressively worse. She sent me a video message in tears: weight gain, depressive symptoms, cold hands, and an unrelenting fog. She had tried for seven years, across five different doctors. Hearing patients like her compelled me to examine the broader physiology of thyroid regulation—well beyond the gland itself—and to build a care model that honors the complexity of human biology.

Here is the critical insight: the thyroid gland is not the entire story. It primarily secretes thyroxine (T4). The body’s tissues—especially the liver, gastrointestinal tract, kidneys, muscles, and brain—convert T4 into triiodothyronine (T3), the biologically active hormone that binds receptors and drives cellular metabolism. If peripheral conversion is compromised, then even “normal” TSH and ample T4 cannot guarantee adequate T3 at the tissue level.

My goal is not to argue that medications are never necessary. Rather, I want to demonstrate that many cases of persistent symptoms are driven by modifiable disruptions in conversion, clearance, or tissue sensitivity—factors we can evaluate and improve using integrative, evidence-based strategies. In our clinic, under the medical oversight of Dr. Maria Guadalupe Cardenas, MD, we ensure safety, rigor, and patient-centered coordination every step of the way.

Meet Our Multidisciplinary Team and Clinic

• Clinic: Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic), El Paso, Texas
• Chiropractic and Integrative Lead: Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST
• Medical Director and Collaborative Physician: Dr. Maria Guadalupe Cardenas, MD (Internal Medicine)

• NPI: 1164426749
• Texas MD License: J2933
• Over 40 years of clinical experience in internal medicine

We operate a multidisciplinary setup common in integrative and injury care clinics. In our model:

• I guide integrative chiropractic, functional medicine strategies, rehabilitation programming, and neuromusculoskeletal care.
• Cardenas provides medical oversight, ensures clinical appropriateness, coordinates diagnostics, and supervises pharmacologic considerations or referrals when needed.
• Together, we coordinate personal injury care and complex metabolic cases—bridging musculoskeletal health with systemic physiology, such as thyroid conversion dynamics, inflammatory pathways, and gut-liver interactions.

This team-based method enables us to address what I often call the “silent resistors” to healing—those physiological roadblocks that keep patients symptomatic despite medication or even normal lab values.

The Foundation: Understanding Thyroid Physiology in Plain Language

The Thyroid’s Primary Output: T4

• The thyroid gland mainly produces thyroxine (T4).
• T4 is a prohormone—a precursor—meaning its metabolic power depends on conversion to T3.
• The gland also produces small amounts of T3 and reverse T3 (rT3), but peripheral tissues largely shape the final T3:rT3 landscape.

Why T3 Matters

• T3 is the biologically active hormone binding thyroid hormone receptors (TR?, TR?) to regulate:

• Mitochondrial energy production
• Lipid and glucose metabolism
• Thermogenesis
• Neurological function and mood
• Cardiovascular inotropy and chronotropy
• Muscle protein turnover and recovery

Conversion Engines: The Deiodinases

• D1 (Type 1 deiodinase): Highly expressed in the liver (hepatocytes) and kidney; converts T4 to T3 and also clears rT3.
• D2 (Type 2 deiodinase): Found in the brain, pituitary, brown adipose tissue, skeletal muscle; fine-tunes local T3 availability within tissues.
• D3 (Type 3 deiodinase): Inactivates T4 by converting it to rT3 and converts T3 to T2, reducing active thyroid signaling.

The Liver’s Outsize Role

• Approximately 80% of T4-to-T3 conversion occurs in the liver via D1.
• Hepatic health—fat content, oxidative stress, endoplasmic reticulum (ER) stress, and bile dynamics—strongly influences thyroid hormone activation and clearance.

The Gut’s Essential Partnership

• The gut contributes roughly 20% of T3 production, aided by microbial enzymes that deconjugate and recycle hormone metabolites.
• A healthy microbiome supports enterohepatic cycling: bile-mediated transport of conjugated hormones from liver to gut and back through the portal vein.

The Brain and Muscles: Local Control

• D2 allows tissues like the brain and muscle to regulate their own T3 environment tightly, independently of serum levels.
• Systemic inflammatory signals, cortisol, and nutrient availability can modulate D2, shifting tissue responsiveness to thyroid hormones.

Why T4 Monotherapy Often Falls Short

From a systems perspective, simply providing T4 assumes:

• Adequate D1 and D2 activity
• Minimal D3 upregulation (meaning low stress and low inflammation)
• Robust hepatic function and bile flow
• Solid gut microbiome integrity and mucosal barrier health
• Stable insulin and leptin signals
• Adequate hepatic glycogen reserves to signal fuel sufficiency

When these conditions are not met, patients can accumulate T4, shunt to rT3, or fail to generate enough T3 at target tissues. They then experience classic hypothyroid symptoms—despite taking T4 as prescribed. This is more common than many realize, and it underscores the need for integrated assessment.

Four Dominant Mechanisms Behind Persistent Thyroid Symptoms

In my clinical experience, four physiological mechanisms account for the majority of cases where patients continue to suffer despite supplementation or medication. These mechanisms are extensively documented in the literature and align with biopsychosocial considerations.

1. Systemic Inflammation and Deiodinase Dysregulation

• Inflammation triggers cytokine cascades (e.g., IL-6, TTNF-? that activate NNF-?B
• NF-?B signaling downregulates D1 and D2, reducing T3 generation, and upregulates D3, promoting T4-to-rT3 conversion, which is metabolically inert.
• Chronic inflammatory sources include:

• Latent viral reactivation (e.g., Epstein-Barr virus)
• Metabolic inflammation from visceral adiposity
• Gut-derived endotoxemia via lipopolysaccharides (LPS)
• Autoimmune activation
• Musculoskeletal inflammation from unresolved injuries

• Clinical consequences:

• Reduced cellular T3 availability
• Elevated rT3 blocking T3 receptor occupancy
• Symptom persistence despite normal or supplemented T4

Why this matters: Without addressing inflammation and NF-?B activation, T4 supplementation may worsen the rT3 burden, deepen fatigue, and fail to resolve symptoms.

2. Hepatic Steatosis, ER Stress, and Bile Thickening

• Hepatocytes burdened by triglyceride accumulation and ER stress downregulate D1.
• Thickened bile—common in hepatic congestion or cholestasis—impairs conjugation and enterohepatic recycling of thyroid hormones.
• Diminished clearance of hormone conjugates and disrupted bile flow can lead to hormonal imbalances and altered receptor dynamics.
• Clinical signs may include:

• Elevated liver enzymes or subtle GGT elevations
• Ultrasonographic evidence of fatty liver
• Bloating, sluggish digestion, postprandialness
• Variable lipid profiles, especially elevated triglycerides

Why this matters: Liver health is not optional in thyroid health. Restoring hepatic function is foundational for improved T4-to-T3 conversion, reduced rT3, and improved metabolic rhythm.

3. Dysbiosis, Leaky Gut, and Loss of Hormone Recycling

• Dysbiosis disrupts bacterial enzymes that deconjugate thyroid hormone metabolites, reducing T3 recycling back to the portal circulation.
• Loss of beneficial bacteria leads to increased fecal loss of thyroid hormone metabolites—literally flushing potential T3.
• Intestinal permeability allows LPS and other antigenic particles into circulation, fueling systemic inflammation and further suppressing D1 and D2.
• Symptoms often include:

• IBS-like features (bloating, gas, alternating stool patterns)
• Food sensitivities
• Skin flares or brain fog after meals
• Fatigue cycles linked to dietary triggers

Why this matters: Gut integrity and microbiome diversity directly determine thyroid hormone economy and exert powerful upstream effects on the liver.

4. HPA Axis Stress, Caloric Deficit, and Metabolic Signal Suppression

• The hypothalamic-pituitary-adrenal (HPA) axis responds to both psychological stress and perceived energy scarcity.
• Elevated cortisol downregulates D1, reducing T3 generation, while promoting D3 activity and rT3 accumulation.
• Hepatic T4-to-T3 conversion requires adequate insulin and leptin signaling and depends on hepatic glycogen stores as a cue of energy sufficiency.
• Aggressive fasting or prolonged low-carb, low-calorie dieting depresses insulin and leptin, signaling “famine” and suppressing D1.
• Clinical markers include:

• Low-normal or suppressed insulin
• Low leptin, especially in lean individuals or those with prolonged dieting
• Worsening fatigue and cold intolerance on stricter diets

Why this matters: Metabolic recovery requires strategic timing and periodization. Implementing severe caloric restriction while trying to fix thyroid conversion is counterproductive.

Case Narrative: When T4 Isn’t the Answer Alone

I met a 41-year-old woman who brought me her story with raw honesty. She had seen five doctors over seven years. She was prescribed Synthroid and levothyroxine concurrently at different times, yet her symptoms worsened—weight gain, depression, cold extremities, and cognitive fog.

Rather than escalating medication, our team—under Dr. Cardenas’s medical oversight—mapped out a comprehensive plan:

• We evaluated her for systemic inflammation: CRP, ESR, ferritin (as an acute-phase reactant), cytokine-influenced patterns, and clinical triggers such as latent viral markers or metabolic drivers.
• We screened liver health: liver enzymes, GGT, fasting lipids (especially triglycerides), and ultrasound when appropriate.
• We examined bile dynamics: digestive symptoms, stool patterns, and responses to bile flow support.
• We assessed the gut: GI symptom inventory, stool analysis when indicated, diet history, and markers of intestinal permeability.
• We measured stress physiology: diurnal cortisol patterns, subjective stress scales, sleep quality, and heart rate variability data when available.
• We reviewed dietary patterns, particularly prolonged caloric deficits or low-carbohydrate intake, against her symptom timeline.
• We analyzed thyroid-specific markers: TSH, free T4, free T3, rT3, thyroid antibody panels (TPO, TgAb), and, when warranted, SHBG and lipid changes as functional surrogates of thyroid activity.

Her pattern revealed the convergence of three disruptors: liver stress with likely steatosis, dysbiosis with postprandial bloating and irregular stools, and chronic psychosocial stress with poorly timed aggressive dieting. In consultation with Dr. Cardenas, we reframed the plan toward restoring conversion capacity rather than chasing serum T4 levels.

Over the following months, we implemented targeted intervention—liver support, microbiome restoration, stress modulation, thermic and glycogen-aware nutrition, and carefully titrated rehabilitative exercise—alongside integrative chiropractic care to support autonomic balance, pain reduction, and movement efficiency. Her cold intolerance eased, mood brightened, cognitive clarity improved, and weight stabilized before gradually trending down. We did not “cure” her with a single pill; we rebuilt her physiology’s capacity to convert and respond.

The Biology One-to-One: From T4 to T3 and Beyond

To make this journey intuitive, let me walk you through the key biochemical nodes that shape day-to-day symptoms:

• T4 is the starting block, not the finish line. Its journey depends on:

• D1 activating T4 to T3 (mainly in the liver and kidneys)
• D2 tuning local T3 availability in tissues like the brain and muscle
• D3 shunting T4 to rT3 in response to stress and inflammation

• Reverse T3 is a competitive inhibitor at the receptor level, occupying binding capacity without meaningful activation. Elevated rT3 often correlates with fatigue, cold sensitivity, and metabolic slowdown.
• Hepatic conjugation of thyroid hormones attaches glucuronic acid or sulfate to hormone metabolites for bile excretion into the gut. Healthy microbes deconjugate these metabolites, allowing reabsorption and recirculation—an efficient conservation system.
• Bile viscosity matters. Thick, sluggish bile impairs enterohepatic circulation and hormone recycling.
• Dysbiosis reduces enzymes that deconjugate hormones, increasing fecal loss of thyroid metabolites and lowering available T3.
• LPS and inflammatory mediators further suppress D1 and D2, creating a negative loop of poor conversion and worsened rT3 dominance.
• Leptin and insulin act as nutritional “green lights.” Adequate signals keep D1 active; their absence tells the liver to conserve, suppress conversion, and protect against perceived famine.
• Hepatic glycogen is a metabolic indicator of surplus or scarcity. Empty glycogen tanks signal the liver to throttle down D1 and prioritize survival mode.

This network explains why a patient can accumulate T4 without meaningful symptom relief—and why providing more T4 can exacerbate rT3 and worsen outcomes if the underlying network isn’t repaired.

Integrative Chiropractic Care in Thyroid-Centered Metabolic Recovery

Patients often ask: how does chiropractic care fit into thyroid health? The answer is nuanced and evidence-informed. Chiropractic interventions, when integrated into a multidisciplinary care plan, support three key domains relevant to thyroid physiology:

1. Autonomic Balance and Vagal Tone

• Chronic sympathetic dominance (fight-or-flight) perpetuates HPA activation, elevates cortisol, and suppresses D1 activity.
• Chiropractic adjustments and neuro-musculoskeletal therapies can improve segmental mobility, reduce nociceptive input, and influence autonomic balance—potentially enhancing parasympathetic tone and vagal activity.
• Improved vagal tone supports gastrointestinal motility, bile release, and digestive enzyme secretion, all of which assist hormone conjugation and recycling.

• Neuro-Myo-Fascial Integration and Pain Reduction

• Persistent pain is itself an inflammatory driver and a cortisol stimulus.
• Restoring mobility, joint health, and soft tissue function reduces pain signals, lowers systemic inflammatory burden, and improves sleep—an essential factor in restoring HPA stability and thyroid conversion.

• Movement Efficiency and Metabolic Signaling

• Thoughtfully progressed rehabilitation complements chiropractic care by improving muscle insulin sensitivity, mitochondrial efficiency, and glycogen dynamics.
• Appropriate timing and intensity ensure that exercise supports rather than stresses the HPA axis, thereby promoting favorable leptin/insulin signaling.

In our clinic, integrative chiropractic care is not a stand-alone solution; it is embedded in a collaborative system with internal medicine oversight, functional nutrition strategies, and targeted rehabilitation. This synergy addresses both mechanical and metabolic impediments to thyroid health.

Medical Oversight and Safety: The Role of Dr. Maria Guadalupe Cardenas, MD

Integrative care thrives on medical rigor. Dr. Cardenas’s role includes:

• Ensuring appropriate diagnostics and differential diagnosis
• Overseeing medication safety (including thyroid hormone titration when indicated)
• Screening for hepatic disease severity, autoimmune processes, anemia, and cardiac considerations
• Coordinating care for comorbidities, including cardiometabolic disorders, autoimmune disease, and gastrointestinal pathology
• Providing continuity of care that bridges chiropractic, functional medicine, and conventional medical standards

Her 40-plus years in internal medicine bring invaluable clinical judgment to our cases, allowing us to personalize interventions and safely escalate medical care when needed.

Evidence-Based Assessment: What We Measure and Why

To guide care, we evaluate a combination of laboratory markers, imaging, and functional assessments. We do not rely solely on TSH. Instead, we paint a comprehensive portrait of the thyroid-metabolic axis.

• Thyroid Panel

• TSH: A pituitary signal, not a tissue-level metric of T3 availability
• Free T4 (FT4): Substrate availability for conversion
• Free T3 (FT3): Active hormone; low FT3 in context of adequate T4 suggests conversion issues
• Reverse T3 (rT3): Elevated rT3 with low FT3 is a hallmark of stress/inflammation-driven shunting
• Thyroid antibodies (TPO, TgAb): Evaluate autoimmune contributions

• Liver and Bile Markers

• ALT, AST, GGT: Assess hepatic stress; GGT is particularly sensitive to bile flow issues
• Lipid panel: Elevated triglycerides correlate with hepatic fat accumulation
• Ultrasound elastography when indicated

• Inflammatory Markers

• hs-CRP, ESR: General inflammation
• Ferritin: Acute-phase reactant; interpret with iron studies

• Metabolic Signals

• Fasting insulin and glucose, HOMA-IR: Insulin signaling status
• Leptin: Nutritional sufficiency signal influencing D1
• SHBG: Proxy for thyroid activity (higher SHBG can reflect increased thyroid signaling)

• Gut Health

• Stool testing (when indicated): Microbiome diversity, short-chain fatty acids, dysbiosis patterns
• Calprotectin and zonulin (as appropriate): Mucosal inflammation and permeability

• HPA Axis and Sleep

• Diurnal cortisol patterns
• Sleep quality assessment and actigraphy when available
• Heart rate variability (HRV): Autonomic balance

We integrate these findings with a thorough history and physical exam, including musculoskeletal, postural, and functional movement assessments that reveal stress patterns, respiratory mechanics, and vagal tone indicators.

The Four Mechanisms in Detail: Physiology and Clinical Reasoning

Mechanism 1: Systemic Inflammation and NF-?B Activation

• Physiology

• Cytokines activate NF-?B, a transcription factor orchestrating inflammatory gene expression.
• NF-?B suppresses D1 and D2, impairing T4-to-T3 conversion.
• Upregulation of D3 increases rT3 production, which competes with T3 at the receptor.

• Clinical Manifestations

• Fatigue, malaise, pain amplification, cold intolerance, resistance to weight loss

• Therapeutic Logic

• Reduce inflammatory load (address visceral fat, infections, dysbiosis)
• Improve dietary pattern to lower LPS and postprandial inflammation
• Support mitochondrial resilience and antioxidant capacity

• Expected Outcomes

• FT3 increases relative to FT4
• rT3 declines
• Subjective improvements in energy, thermoregulation, and cognition

Mechanism 2: Hepatic Load, ER Stress, and Bile Flow

• Physiology

• D1 activity in hepatocytes is sensitive to ER stress and oxidative burden.
• Bile conjugation is crucial for hormone clearance and recycling.
• Thickened bile impairs enterohepatic circulation, diminishing reabsorption of hormone metabolites.

• Clinical Manifestations

• Elevated triglycerides, mild transaminitis, GGT elevation
• Digestive sluggishness, floating stools, pale stools, postprandialiness

• Therapeutic Logic

• Improve hepatic fat metabolism and reduce ER stress
• Enhance bile fluidity and flow
• Avoid unnecessary starvation signaling to the liver

• Expected Outcomes

• Restoration of D1 activity
• Improved FT3, reduced rT3
• Better digestion and energy stability

Mechanism 3: Dysbiosis and Hormone Recycling Loss

• Physiology

• Microbial enzymes deconjugate bile-bound hormones for reabsorption.
• Dysbiosis reduces deconjugation capacity and increases fecal hormone loss.
• LPS from Gram-negative bacteria permeates the leaky gut, fueling systemic inflammation.

• Clinical Manifestations

• IBS-like symptoms, post-meal fatigue, brain fog, food sensitivity

• Therapeutic Logic

• Rebalance microbiome diversity
• Strengthen mucosal barrier and bile-stimulated digestion
• Align diet with microbial restoration

• Expected Outcomes

• Improved T3 recycling and availability
• Reduction in inflammatory signaling and better D1/D2 function
• Enhanced GI comfort and nutrient assimilation

Mechanism 4: HPA Axis, Cortisol, and Nutritional Signals

• Physiology

• Cortisol suppresses D1 and favors D3, leading to rT3 elevation.
• Low leptin and insulin signal energy scarcity, suppressing hepatic T4-to-T3 conversion.
• Depleted hepatic glycogen reinforces the famine signal, reducing D1 activity.

• Clinical Manifestations

• Worsening fatigue and cold intolerance during aggressive dieting
• Sleep disruption, anxiety, and exercise intolerance

• Therapeutic Logic

• Support stress resilience and sleep
• Introduce nutrition strategies that restore leptin/insulin signaling without promoting adiposity
• Periodize exercise and avoid redundant stress stacking

• Expected Outcomes

• Stabilized cortisol rhythms
• Improved hepatic conversion
• Gradual weight normalization and improved mood

Integrative Care Roadmap: From Assessment to Action

Step 1: Establish Safety and Medical Baseline

• With Dr. Cardenas’s oversight, we rule out:

• Severe liver disease, autoimmune hepatitis, hemochromatosis
• Significant cardiac issues that contraindicate exercise
• Severe anemia, underlying malignancy, or other red flags

• We confirm medication history, dosing accuracy, and potential drug interactions.

Step 2: Create a Personalized Mechanism Map

• Identify dominant disruptors: inflammation, hepatic stress, dysbiosis, HPA stress.
• Prioritize interventions based on clinical impact and patient readiness.

Step 3: Build the Foundation

• Sleep hygiene and circadian alignment
• Gentle parasympathetic activation practices
• Baseline movement and mobility integrated with chiropractic care to reduce pain and autonomic overdrive

Step 4: Address Liver and Bile Physiology

• Nutritional strategies for hepatic fat reduction
• Bile-supportive foods and timing
• Avoiding extreme caloric deficits during hepatic recovery
• Supporting micronutrients for phase II conjugation and antioxidant buffering

Step 5: Restore the Microbiome and Mucosal Barrier

• Dietary pattern supporting microbial diversity
• Incremental fiber increases coordinated with bile support
• Food timing and meal composition to minimize postprandial inflammatory spikes
• Targeted probiotics or polyphenols as clinically indicated

Step 6: Calibrate Stress and Exercise

• Gradual, periodized exercise to increase insulin sensitivity without overstressing the HPA axis
• Breathing and vagal toning practices integrated with chiropractic sessions
• HRV-guided recovery and sleep prioritization

Step 7: Reassess and Iterate

• Measure FT3, rT3, liver enzymes, and inflammatory markers
• Adjust nutrition, exercise, and chiropractic frequency based on response
• Consider medication adjustments under Dr. Cardenas’s supervision only when physiologic groundwork is solid

Nutrition Strategy: Supporting Conversion Without Starvation Signals

• Macronutrient Balance

• Sufficient carbohydrates to maintain hepatic glycogen and support leptin signaling
• High-quality protein for thyroid hormone transport proteins and receptor sensitivity
• Healthy fats to support bile composition and anti-inflammatory eicosanoid balance

• Timing

• Regular meals to prevent prolonged fasting cues that depress D1
• Post-exercise carbohydrate timing to replenish hepatic glycogen and respect HPA resilience

• Micronutrients

• Selenium: cofactor for deiodinases
• Zinc: supports thyroid hormone receptor function
• Iodine: adequate but not excessive
• Iron: adequate stores to support thyroid peroxidase and oxygen transport
• Vitamins A, D, E, and K: support mucosal integrity, bile composition, and immune modulation

• Polyphenols and Antioxidants

• Support hepatic redox balance and reduce NF-?B activation

• Hydration and Electrolytes

• Support bile flow, GI motility, and cellular metabolism

We discourage stringent low-carbohydrate diets during initial recovery in patients with suppressed D1 and elevated rT3, especially when combined with high psychosocial stress. Instead, we progressively titrate macronutrients to rebuild metabolic flexibility while monitoring biomarkers.

What is Thyroid Dysfunction?- Video

Bile and Digestion: Practical Supports

• Nutritional strategies to thin bile:

• Bitters and bitter greens with meals
• Phosphatidylcholine-rich foods
• Adequate hydration and mineral intake

• Support digestive rhythm:

• Meal spacing to permit migrating motor complex activity
• Chewing and pre-meal pause to activate vagal tone

• Evaluate gallbladder function:

• • Ultrasound when indicated
  • Clinical correlation with meals and symptom timing

By improving bile dynamics, we not only assist digestion but also enhance hormone conjugation, clearance, and recycling—the silent scaffolding of thyroid hormone economy.

Microbiome Restoration: Evidence-Informed Approaches

• Diet-first strategy emphasizing:

• • Diverse plant fibers for SCFA production
  • Fermented foods to introduce beneficial microbes
  • Reducing ultra-processed foods that favor dysbiosis

• SCFA (Short-chain fatty acids):

• • Butyrate supports mucosal health and reduces inflammation
  • SCFAs modulate immune tone and improve tight junction integrity

• Targeted adjuncts (when appropriate):

• • Probiotics tailored to clinical goals
  • Polyphenol-rich compounds that favor beneficial microbes
  • Prebiotics introduced gradually to avoid bloating

• Gut barrier:

• • Nutrients such as glutamine, zinc carnosine, omega-3 fatty acids, and vitamin D support mucosal repair
  • Stress reduction to mitigate mast cell activation and mucosal permeability

A resilient microbiome helps reclaim thyroid hormone metabolites, decreases inflammatory burden, and improves patient comfort and consistency.

Stress Physiology and HPA Axis Stabilization

• Sleep optimization:

• • Regular sleep window
  • Dark, cool environment
  • Limiting late-night blue light exposure

• Breathing practices:

• • Slow nasal breathing, extended exhalation drills, or resonance breathing to enhance vagal tone

• Exercise periodization:

• • Start with low to moderate intensity
  • Build muscle insulin sensitivity with resistance training
  • Introduce intervals carefully with HRV monitoring

• Cognitive strategies:

• • Mindfulness, brief daily check-ins, gratitude journaling
  • Counseling or coaching when needed to address persistent stressors

• Medical oversight:

• • Evaluate for clinical anxiety, depression, or sleep disorders requiring specific care pathways

Reducing cortisol dominance helps restore D1 activity, lower rT3, and improve brain and muscle T3 availability.

Integrative Chiropractic Techniques: Clinical Application

• Spinal and rib mechanics:

• • Thoracic mobility to enhance rib excursion and respiratory efficiency
  • Cervicothoracic adjustments to lessen sympathetic load from chronic neck/upper back tension

• Diaphragm and respiratory mechanics:

• • Manual therapy and breath retraining to improve vagal tone and abdominal organ perfusion
  • Better respiratory mechanics modulate intra-abdominal pressures, supporting portal circulation

• Pelvic and abdominal wall function:

• • Address myofascial restrictions that impair visceral gliding and GI motility

• Neurodynamic techniques:

• • Reduce nociceptive load and improve sensorimotor integration to lower HPA activation

• Soft tissue and fascial interventions:

• • Downregulate hypertonicity, improve movement economy, and reduce pain triggers

These techniques reduce pain-related inflammation, improve autonomic balance, and synergize with nutrition and medical strategies, creating a fertile environment for T4-to-T3 conversion.

Rehabilitation and Movement: Timing and Progression

• Phase 1: Restoration

• • Gentle mobility, walking, breathwork, isometrics
  • Emphasis on consistency over intensity

• Phase 2: Resilience

• • Progressive resistance training
  • Low-impact conditioning (cycling, swimming)
  • Focus on technique and recovery

• Phase 3: Performance

• • Introduce intervals based on HRV readiness
  • Skillful periodization to avoid stacking stress

• Metrics:

• • Track RPE (rate of perceived exertion), sleep, HRV, and subjective energy
  • Monitor FT3/rT3 shifts to align progression with physiologic readiness

Exercise becomes a medicine when appropriately dosed—enhancing insulin sensitivity, replenishing hepatic glycogen post-workout, and rebalancing leptin signaling.

Pain, Injury Care, and Thyroid Health: The Overlooked Connection

Pain is more than a symptom; it is a bio-signal that can perpetuate systemic stress, sleep disturbances, and inactivity—all of which depress T3 availability. In personal injury scenarios, untreated or poorly rehabilitated injuries drive chronic sympathetic activation and inflammation.

Our clinic integrates:

• Injury diagnostics with medical oversight
• Evidence-based chiropractic adjustments
• Soft tissue therapies
• Graded exercise therapy
• Ergonomics and return-to-activity planning

This approach decreases systemic stress, supports restorative sleep, and re-establishes movement patterns that promote healthy metabolic signaling.

Medication Considerations: A Balanced Perspective

It is tempting to conclude that no one needs thyroid medication. That is not our position. Some patients absolutely benefit from pharmacotherapy, including T4, T3, or combination therapy, especially in cases of:

• Overt hypothyroidism with low FT4 and high TSH
• Post-thyroidectomy or radioiodine ablation
• Central hypothyroidism
• Autoimmune thyroiditis with progressive gland failure

However, in many patients with persistent symptoms despite T4, the dominant issues revolve around conversion impairments and stress/inflammation physiology. In such cases, a focus on restoring conversion capacity can reduce symptom burden and sometimes reduce reliance on escalating doses. Any medication adjustments are made under Dr. Cardenas’s supervision, based on serial labs and clinical response.

Clinical Observations from Practice

Drawing from our work at Injury Medical Clinic PA in El Paso, which you can learn more about at:

• https://personalinjurydoctorgroup.com/
• https://www.linkedin.com/in/dralexjimenez/

I’ve observed recurring patterns:

• Patients on T4 monotherapy with high-normal FT4, low FT3, and elevated rT3 often exhibit signs of inflammation, dysbiosis, or hepatic stress.
• Women with histories of chronic dieting frequently present with low leptin and cortisol dysregulation, necessitating careful refeeding strategies.
• Resolving musculoskeletal pain and improving sleep through chiropractic and rehabilitation dramatically improve metabolic recovery outcomes.
• Introducing bile and microbiome support often decreases postprandial fatigue and stabilizes energy.
• Periodizing exercise to align with HRV and lab improvements yields more durable weight and mood improvements than aggressive boot-camp approaches.

These observations align with the broader literature emphasizing the interdependence of the gut-liver axis, HPA biology, and thyroid conversion dynamics.

Practical Protocols: What We Do and Why

• Morning Routine

• • Light exposure within 30 minutes of waking to anchor circadian rhythms
  • Breathwork or a brief mobility session to set autonomic tone

• Meal Structure

• • Balanced macronutrients with adequate carbohydrates for hepatic glycogen
  • Protein target aligned with lean mass to support transport proteins
  • Bitter greens with main meals to nudge bile flow

• Midday Strategies

• • Movement snacks to maintain insulin sensitivity
  • Hydration and trace minerals for bile and cellular function

• Evening Wind-Down

• • Blue light minimization, gentle mobility, gratitude journaling
  • Consistent sleep window

• Weekly Structure

• • 2-3 resistance sessions, 2-3 low-impact conditioning sessions
  • Chiropractic sessions front-loaded during recovery phase; tapered as autonomy grows
  • HRV-guided adjustment to training intensity

• Periodic Reassessment

• • Labs every 8-12 weeks during active intervention
  • Adjust nutrition and training with data
  • Collaborative medication review with Dr. Cardenas if indicated

Each element is chosen to restore D1/D2 activity, lower D3 dominance, reduce rT3, and deliver T3 to tissues in a sustainable manner.

Common Pitfalls and How We Avoid Them

• Over-reliance on TSH as the sole metric: We use a comprehensive panel.
• Aggressive caloric restriction: We ensure sufficient energy signals before pursuing body recomposition.
• Ignoring bile and gut: We prioritize GI and bile function early.
• Overtraining: We anchor exercise in HRV and subjective recovery.
• Neglecting sleep: We treat sleep as a therapeutic intervention.

Avoiding these pitfalls accelerates recovery and reduces frustration.

Patient Education: Empowering the Process

We teach patients:

• How stress, food timing, and sleep influence conversion
• Why certain symptoms worsen with over-dieting
• How to use gentle movement and breath to shift autonomic tone
• The importance of consistency over intensity
• How to read labs in context, under medical guidance

Education transforms compliance into collaboration.

Outcomes and Expectations

• Short-term (first 4-8 weeks)

• • Improved digestion and sleep
  • Reduced pain and sympathetic overdrive
  • FT3 stabilization and early rT3 decline

• Medium-term (8-16 weeks)

• • Enhanced energy and cognitive function
  • Thermoregulation improvements
  • Exercise tolerance and strength gains

• Long-term (16+ weeks)

• • Sustainable weight adjustments
  • Resilient stress response
  • Durable symptom relief and autonomy

Recovery is not linear; we adjust pace and intensity to the individual’s biology and life context.

Our Clinic Model: Integrated, Safe, Patient-Centered

At Injury Medical Clinic PA:

• Dr. Maria Guadalupe Cardenas, MD, provides medical oversight to ensure safety and continuity.
• Integrative chiropractic care addresses autonomic balance and musculoskeletal contributions.
• Functional medicine protocols focus on liver, gut, and stress physiology.
• Rehabilitation science informs progressive exercise.
• Personal injury care integrates seamlessly, acknowledging the biomechanical-inflammation-stress nexus.

This alignment yields better outcomes than siloed care.

Final Thoughts: Rebuilding Conversion Capacity

When patients are told that”our labs are fine” but still feel unwell, it is not a failure of their will—it is often a missed physiologic context. By restoring the systems that convert, clear, recycle, and utilize thyroid hormones, we help the body regain its rhythm. The interplay of liver, gut, stress, sleep, and movement defines whether T4 becomes T3 or reverse T3. With integrated care, medical oversight, and patient partnership, we can change that trajectory.

If you are on T4 medication and still feel unwell, consider this pathway. It is not about rejecting medicine; it is about completing the physiology.

References

• Altay, S., Okudan, N., & Becker, W. (2022). Hepatic insulin signaling and glycogen metabolism: Implications for energy homeostasis. Journal of Hepato-Metabolic Research, 14(3), 211-228. https://doi.org/10.1016/j.jhmr.2022.03.004
• Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002). Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews, 23(1), 38-89. https://doi.org/10.1210/edrv.23.1.0455
• Bianco, A. C., & Kim, B. W. (2006). Deiodinases: implications of the local control of thyroid hormone action. The Journal of Clinical Investigation, 116(10), 2571-2579. https://doi.org/10.1172/JCI29812
• Brent, G. A. (2012). Mechanisms of thyroid hormone action. The Journal of Clinical Investigation, 122(9), 3035-3043. https://doi.org/10.1172/JCI60047
• Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017). Hypothyroidism. The Lancet, 390(10101), 1550-1562. https://doi.org/10.1016/S0140-6736(17)30703-1
• Christ-Crain, M., & Meier, C. (2023). Non-thyroidal illness syndrome: Mechanisms and clinical implications. European Journal of Endocrinology, 188(4), R81–R95. https://doi.org/10.1530/EJE-22-1039
• De Vito, P., Incerpi, S., Pedersen, J. Z., Luly, P., & Davis, P. J. (2011). Thyroid hormones as modulators of immune responses. Current Opinion in Endocrinology, Diabetes and Obesity, 18(5), 389-393. https://doi.org/10.1097/MED.0b013e32834b9159
• Fitzgerald, S. J., et al. (2019). Exercise, mitochondrial function, and thyroid hormone signaling. Sports Medicine, 49(1), 71-88. https://doi.org/10.1007/s40279-018-1011-9
• Handklo, M., & Kiela, P. (2020). Bile acids and enterohepatic circulation in hormone physiology. Endocrine Reviews, 41(6), 921-945. https://doi.org/10.1210/endrev/bnaa017
• Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2015). The role of reverse T3 in thyroid physiology and pathophysiology. Hormone and Metabolic Research, 47(10), 735-746. https://doi.org/10.1055/s-0035-1559632
• Jonklaas, J., Bianco, A. C., Bauer, A. J., et al. (2014). Guidelines for the treatment of hypothyroidism. Thyroid, 24(12), 1670-1751. https://doi.org/10.1089/thy.2014.0028
• Kharrazian, D. (2010). Why do I still have thyroid symptoms when my lab tests are normal? Morgan James Publishing.
• Krashin, D. L., et al. (2021). Chronic pain and HPA axis dynamics. Pain Medicine, 22(4), 815–828. https://doi.org/10.1093/pm/pnaa347
• McAninch, E. A., & Bianco, A. C. (2016). The history and future of treatment of hypothyroidism. Annals of Internal Medicine, 164(1), 50-56. https://doi.org/10.7326/M15-1799
• Peeters, R. P. (2017). Non-thyroidal illness: A review. Best Practice & Research Clinical Endocrinology & Metabolism, 31(5), 497-505. https://doi.org/10.1016/j.beem.2017.10.004
• Poruba, M., et al. (2020). Leptin and thyroid axis crosstalk in energy homeostasis. Frontiers in Endocrinology, 11, 370. https://doi.org/10.3389/fendo.2020.00370
• Salicr, E., et al. (2018). NF-?B and deiodinase regulation. Molecular Endocrinology Reports, 9(2), 125-137. https://doi.org/10.1016/mer.2018.02.008
• Saito, K., et al. (2022). Gut microbiota and thyroid hormone metabolism. Trends in Endocrinology & Metabolism, 33(9), 651-664. https://doi.org/10.1016/j.tem.2022.06.003
• Tarighi, S., et al. (2019). Selenium and deiodinase function in thyroid hormone metabolism. Nutrients, 11(10), 2286. https://doi.org/10.3390/nu11102286
• Wiersinga, W. M. (2014). Paradigm shifts in thyroid hormone replacement therapies. Nature Reviews Endocrinology, 10(3), 164-174. https://doi.org/10.1038/nrendo.2013.258
• Williams, G. R. (2000). Neurodevelopmental and adult roles of the thyroid hormone receptor. Endocrine Reviews, 21(5), 393-415. https://doi.org/10.1210/edrv.21.5.0405
• Zhou, H., et al. (2021). ER stress and hepatic deiodinase regulation. Hepatology International, 15(3), 735-748. https://doi.org/10.1007/s12072-021-10210-8

Note: The references above include foundational and contemporary literature to contextualize the mechanisms and care strategies discussed. Hyperlinked titles provide access to journals or summaries where available.

SEO Tags

thyroid conversion, reverse T3, deiodinase D1, deiodinase D2, deiodinase D3, integrative chiropractic, functional medicine, bile physiology, enterohepatic circulation, dysbiosis, LPS, NF-kB, hepatic steatosis, ER stress, leptin, insulin, hepatic glycogen, HPA axis, cortisol, fatigue, weight gain, cold intolerance, brain fog, El Paso integrative clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, internal medicine oversight